Gene · 338442
Papers1,788
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,788
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A fast way to lose antibodies. | Immunity | 2026 | 41985448 | PubTator, text mining | PubMed |
| Development and evaluation of a predictive biomarker model based on the niacin flush pathway for differentiating schizophrenia and bipolar disorder. | Schizophr Res | 2026 | 41967301 | PubTator, text mining | PubMed |
| Signaling Through SCFA Receptors Gpr43 and Gpr109a Drives Pro-Inflammatory M1 Macrophage Polarization in Periodontitis. | Mediators Inflamm | 2026 | 41948871 | PubTator, text mining | PubMed |
| Linking Targeted Pancreatic Cancer Genes With Metabolic Disorders: A Cross-Species Translational Pathway. | Cancer Med | 2026 | 41937118 | PubTator, text mining | PubMed |
| Butyrate Silences MUC5AC in Airway Epithelial Cells Through Histone Deacetylation at Its Promoter Region. | Allergy Asthma Immunol Res | 2026 | 41914529 | PubTator, text mining | PubMed |
| Allergic lung inflammation can be modulated by niacin and drives the development of glycolytic eosinophils. | Mucosal Immunol | 2026 | 41912083 | PubTator, text mining | PubMed |
| Hydroxycarboxylic acid receptor 2 (GPR109A) and retinopathies: pathways and prospects. | Front Med (Lausanne) | 2026 | 41889514 | PubTator, text mining | PubMed |
| Targeting the gut-kidney axis to improve kidney transplantation prognosis: from mechanisms to clinical intervention strategies. | Ren Fail | 2026 | 41845903 | PubTator, text mining | PubMed |
| The gut-tumor metabolic axis: A comprehensive exploration of bidirectional crosstalk in cancer immunotherapy. | Crit Rev Oncol Hematol | 2026 | 41839398 | PubTator, text mining | PubMed |
| Microbiota management: a perspective for kidney transplant patients. | Front Transplant | 2026 | 41798990 | PubTator, text mining | PubMed |
| The role of gut microbiota in autoimmune thyroid diseases: nutritional determinants and diet-based modulation. | Front Endocrinol (Lausanne) | 2026 | 41798186 | PubTator, text mining | PubMed |
| Microbial SCFAs as epigenetic mediators: fine-tuning the gut-brain axis in neurodegenerative disorders. | Curr Res Microb Sci | 2026 | 41798063 | PubTator, text mining | PubMed |
| The role of Clostridium butyricum and its metabolites in modulating gut mucosal immunity: implications for viral infections and inflammatory diseases. | Front Immunol | 2026 | 41789065 | PubTator, text mining | PubMed |
| Inflammatory bowel disease through the lens of microbe-host interactions: immunomodulation, metabolic effects, and genetic susceptibility in microbiota dysbiosis. | Front Cell Infect Microbiol | 2026 | 41778020 | PubTator, text mining | PubMed |
| Role of Gut Microbiota in Psychiatric Disorders: From Mechanistic Insights to Therapeutic Strategies. | J Korean Med Sci | 2026 | 41775278 | PubTator, text mining | PubMed |
| Dimethyl fumarate and mitochondrial physiology: implications for neurological disorders. | Front Pharmacol | 2026 | 41769702 | PubTator, text mining | PubMed |
| The bridging role of gut microbiota-derived metabolites in neuropathic pain comorbid with anxiety. | Front Neurosci | 2026 | 41769007 | PubTator, text mining | PubMed |
| Gut microbiota and brain aging: a comparative review of African and western populations. | Front Aging Neurosci | 2026 | 41767845 | PubTator, text mining | PubMed |
| The Effects of Gut Microbiota, Plasma Metabolites, Immune Cells, Blood Cells and Cytokines on Schizophrenia: A Bidirectional Two-Sample Mendelian Randomisation Study. | Actas Esp Psiquiatr | 2026 | 41755577 | PubTator, text mining | PubMed |
| Dietary Fiber in Endometriosis: Mechanisms, Evidence, and Potential Clinical Benefits-Up-to-Date Review. | Nutrients | 2026 | 41754207 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338442/papers?page=2